Please login to the form below

Not currently logged in
Email:
Password:

Merck acquires Amnis Corporation

Merck's Millipore division is to acquire Amnis Corporation, a US-based manufacturer of cell imaging systems

Merck Millipore, known as EMD Millipore in the US and Canada, is to acquire Amnis Corporation, a US-based manufacturer of cell imaging systems.

Merck Millipore is the life sciences division of German pharmaceutical firm Merck.

The transaction is expected to take place before the end of 2011 according to Amnis, with financial terms undisclosed.

Amnis had revenue of $14m (€10m) in 2010 developing, manufacturing and marketing tools for high speed cell imaging for research and diagnostic markets.

Jonathan DiVincenzo, head of the bioscience business unit within Merck Millipore said: "The acquisition of Amnis significantly contributes to our strategy to be a leader in cellular analysis and systems biology."

David A Basiji, co-founder and CEO of Amnis said: "The combination of Amnis with EMD Millipore will greatly accelerate development of novel applications in imaging flow cytometry, enhance our customer support, and accelerate product development."

30th August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...
How Helpful are Simple Health Messages?
...

Infographics